UNSPSC 85583672: Replacement of epiglottis with autologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of epiglottis with autologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CRR77Z

UNSPSC 85583672 Replacement of epiglottis with autologous tissue substitute, via natural or artificial opening (Commodity) shows no relevant recent state and local procurement activity. The code names a specific surgical procedure, but the six recent opportunities posted under this code by state and local issuing bodies procure independent medical evaluations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve epiglottis replacement or tissue-substitute procedures. The mismatch between the code's clinical nomenclature and the actual work being solicited suggests miscoding by the issuing bodies or a fundamental disconnect between the UNSPSC taxonomy and how these jurisdictions tag healthcare administration and staffing contracts.

The opportunities span geographically diverse issuing bodies: the City of Phoenix Retirement Office (Arizona), City of Long Beach (California), Washington State Department of Transportation on behalf of Washington State Ferries, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and County of Santa Clara Health System (California). No issuing body appears more than once, and no pattern of repeat activity under this code emerges. For procurement purposes, this code should be considered dormant or misapplied at the state and local level; firms with actual epiglottis-replacement or tissue-substitute surgical capabilities would find no market signal or relevant solicitation activity to pursue.